Use of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial Infarction

Author:

Kadakia Mitul B.,Desai Nihar R.,Alexander Karen P.,Chen Anita Y.,Foody JoAnne M.,Cannon Christopher P.,Wiviott Stephen D.,Scirica Benjamin M.

Funder

Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership

Genentech

Schering-Plough Corporation

Accumetrics

AstraZeneca

GlaxoSmithKline

Intekrin Therapeutics

Merck

Takeda

Daiichi Sankyo

Eli Lilly

Schering-Plough

Bristol-Myers Squibb

CV Therapeutics

Novartis

Johnson & Johnson

Bayer Healthcare

Michael Lerner Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction;Antman;N Engl J Med,2006

2. Bivalirudin during primary PCI in acute myocardial infarction;Stone;N Engl J Med,2008

3. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial;Yusuf;JAMA,2006

4. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non–Q-wave myocardial infarction;Antman;Circulation,1999

5. Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial;Ferguson;JAMA,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3